Longer-term treatment of patients with bipolar disorder: a 9-month observational study in Central and Eastern Europe, the Middle East and Africa

References

• Salvatore P, Tohen M, Khalsa HM, et al. Longitudinal research on bipolar disorders. Epidemiol Psichiatr Soc 2007;16:109-17
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders, Text Revision (DSM-IV-TR). 4th edn. Arlington VA: American Psychiatric Association, 2000
   Google Scholar
• Gajwani P, Kemp DE, Muzina DJ, et al. Acute treatment of mania: an update on new medications. Curr Psychiatry Rep 2006;8:504-9
   PubMedGoogle Scholar
• Mitchell PB, Malhi GS. The expanding pharmacopoeia for bipolar disorder. Annu Rev Med 2002;53:173-88
   PubMed Web of Science ®Google Scholar
• Zhu B, Kulkarni PM, Stensland MD, et al. Medication patterns and costs associated with olanzapine and other atypical antipsychotics in the treatment of bipolar disorder. Curr Med Res Opin 2007;23:2805-14
   PubMed Web of Science ®Google Scholar
• Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord 2003;73:123-31
   PubMed Web of Science ®Google Scholar
• Perlis RH, Ostacher MJ, Patel JK, et al. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2006;163:217-24
   PubMed Web of Science ®Google Scholar
• Derry S, Moore RA. Atypical antipsychotics in bipolar disorder: systematic review of randomised trials. BMC Psychiatry 2007;7:40
   PubMed Web of Science ®Google Scholar
• Jones RM, Thompson C, Bitter I. A systematic review of the efficacy and safety of second generation antipsychotics in the treatment of mania. Eur Psychiatry 2006;21:1-9
   PubMed Web of Science ®Google Scholar
• Treuer T, Oruc L, Loza N, et al. Acute phase results from STORM, a multicountry observational study of bipolar disorder treatment and outcomes. Psychiatr Danub 2007;19:282-95
   PubMed Web of Science ®Google Scholar
• Spearing MK, Post RM, Leverich GS, et al. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 1997;73:159-71
   PubMed Web of Science ®Google Scholar
• Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133:429-35
   PubMed Web of Science ®Google Scholar
• Gonzalez-Pinto A, Ballesteros J, Aldama A, et al. Principal components of mania. J Affect Disord 2003;76:95-102
   PubMed Web of Science ®Google Scholar
• The EuroQol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208
   PubMed Web of Science ®Google Scholar
• Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:1095-108
   PubMed Web of Science ®Google Scholar
• Faries D, Ascher-Svanum H, Belger M. Analysis of treatment effectiveness in longitudinal observational data. J Biopharm Stat 2007;17:809-26
   PubMed Web of Science ®Google Scholar
• Joffe MM, Ten Have TR, Feldman HI, et al. Model selection, confounder control, and marginal structural models: review and new applications. Am Stat 2004;58:272-9
   Web of Science ®Google Scholar
• Vieta E, Panicali F, Goetz I, et al. Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study. J Affect Disord 2008;106:63-72
   PubMed Web of Science ®Google Scholar
• Hirschfeld RA, Bowden CL, Gitlin MJ, et al. Practice Guideline for the Treatment of Patients with Bipolar Disorder, 2nd edn. American Psychiatric Association, 2002. Available at: http://www.psychiatryonline.com/pracGuide/pracGuideTopic_8.aspx [Last accessed 4 April 2008]
   Google Scholar
• Tohen M, Ketter TA, Zarate CA, et al. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry 2003;160:1263-71
   PubMed Web of Science ®Google Scholar
• Tohen M, Chengappa KN, Suppes T, et al. Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone. Br J Psychiatry 2004;184:337-45
   PubMed Web of Science ®Google Scholar
• Fagiolini A, Kupfer DJ, Masalehdan A, et al. Functional impairment in the remission phase of bipolar disorder. Bipolar Disord 2005;7:281-5
   PubMed Web of Science ®Google Scholar
• Shi L, Juarez R, Hackworth J, et al. Open-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomes. Curr Med Res Opin 2006;22:961-6
   PubMed Web of Science ®Google Scholar
• Henderson DC. Weight gain with atypical antipsychotics: evidence and insights. J Clin Psychiatry 2007;68(Suppl 12):18-26
   PubMedGoogle Scholar
• Keck PE, McElroy SL. Bipolar disorder, obesity, and pharmacotherapy-associated weight gain. J Clin Psychiatry 2003;64:1426-35
   PubMed Web of Science ®Google Scholar
• Hennen J, Perlis RH, Sachs G, et al. Weight gain during treatment of bipolar I patients with olanzapine. J Clin Psychiatry 2004;65:1679-87
   PubMed Web of Science ®Google Scholar
• Tohen M, Calabrese JR, Sachs GS, et al. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am J Psychiatry 2006;163:247-56
   PubMed Web of Science ®Google Scholar
• National Heart Lung and Blood Institute & National Institute of Diabetes and Digestive and Kidney Diseases. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. NIH Publication 98-4083. 1998. Available at: http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.html [Last accessed 4 April 2008]
   Google Scholar
• Lane P. Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches. Pharm Stat 2008;7:93-106
   PubMed Web of Science ®Google Scholar